微创颅内血肿清除术对高血压性基底节区脑出血的疗效

Efficacy of minimally invasive intracranial hematoma evacuation on hypertensive basal ganglia hemorrhage

目的探讨微创颅内血肿清除术对高血压性基底节区脑出血的临床疗效。方法选取在我院住院的高血压性基底节区脑出血患者98例,按治疗方法分为两组,各49例。对照组实施传统保守法治疗,观察组实施微创颅内血肿清除术。比较两组治疗效果。结果观察组治疗总有效率(89.80%)明显高于对照组(61.22%),并发症总发生率和死亡率低于对照组(P<0.05)。两组治疗后第3、7、14、28天及3个月的NIHSS评分均低于治疗后24 h,观察组低于对照祖(P<0.05)。观察组第3、7、14、28天及3个月的BI评分高于对照组(P<0.05)。结论微创颅内血肿清除术治疗高血压性基底节区脑出血创伤小、安全性高。

Objective To evaluate the efficacy of minimally invasive intracranial hematoma evacuation on hypertensive basal ganglia hemorrhage.Methods Ninety-eight patients with hypertensive basal ganglia cerebral hemorrhage in our hospital were selected,and divided into two groups according to treatment methods,with 49 cases in each group.The control group was treated with traditional conservative treatment,and the observation group was treated with minimally invasive intracranial hematoma evacuation.The treatment effects of the two groups were compared.Results The total effective rate of treatment in the observation group(89.80%)was higher than that in the control group(61.22%),and the overall incidence rate of complications and mortality rate were lower than those in the control group(P<0.05).The NIHSS scores at 3,7,14,28 d and 3 months after treatment in both groups were lower than those at 24 hours after treatment,and those in the observation group were lower than the control group(P<0.05).The BI scores at 3,7,14,28 days and 3 months after treatment of the observation group were higher than those of the control group(P<0.05).Conclusion Minimally invasive intracranial hematoma applied on hypertensive basal ganglia hemorrhage has small trauma and high safety.